Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

BNP Paribas Financial Markets Takes Position in BioNTech SE (NASDAQ:BNTX)

Morgan Stanley Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech (BNTX) Faces Investor Concerns Amid FDA Leadership Shift | BNTX Stock News

BioNTech (NASDAQ:BNTX) Price Target Lowered to $132.00 at Morgan Stanley

BioNTech (BNTX) Stock Declines Amid Leadership Changes and Analyst Downgrade

BioNTech (BNTX) Shares Tumble as FDA Announces Leadership Change

BioNTech (BNTX): Citigroup Maintains Rating, Lowers Price Target | BNTX Stock News

BioNTech SE (NASDAQ:BNTX) Q1 2025 Earnings Call Transcript

Baker BROS. Advisors LP Invests $5.13 Million in BioNTech SE (NASDAQ:BNTX)

BioNTech (BNTX) Target Price Lowered by Citi Analyst Amid Quarte

BioNTech SE (NASDAQ:BNTX) Shares Sold by Axa S.A.

BioNTech SE (BNTX) Q1 2025 Earnings Call Highlights: Navigating Challenges and Advancing ...

Appointments and advancements for May 6, 2025 | BioWorld

Q1 2025 Biontech SE Earnings Call Transcript

Health Care Down on Mixed Earnings - Health Care Roundup | Morningstar

BioNTech (BNTX) Price Target Cut by BofA, Buy Rating Maintained | BNTX Stock News

BioNTech (BNTX) Sees Price Target Cut Amid Upcoming Catalysts | BNTX Stock News

BioNTech SE Appoints New CFO to Drive Financial Strategy in Oncology Expansion | BNTX stock news

BioNTech SE (BNTX) Reports Q1 2025 Financial Results and Strategic Updates | BNTX stock news

BioNTech says Novartis executive Zapata-Gomez to become CFO

BioNTech (BNTX) Reveals Q1 Revenue and Advances in Strategic Focus | BNTX Stock News

BioNTech (BNTX) Reports Q1 Loss, Maintains 2025 Financial Guidance

BioNTech (BNTX) Welcomes Ramón Zapata-Gomez as New CFO

BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update | The Manila Times

BioNTech Reports Smaller-Than-Expected Loss, Names New CFO

BioNTech Q1 Loss Widens, Revenues Down; Confirms FY25 Outlook

BioNTech SE Q1 25 Earnings Conference Call At 8:00 AM ET

BNTX Q1 2025 Earnings Report on 5/5/2025

BioNTech SE (NASDAQ:BNTX) Shares Purchased by CANADA LIFE ASSURANCE Co

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

BioNTech (BNTX) Involved in New Vaccine Development Initiative | BNTX Stock News

BioNTech (NASDAQ:BNTX) Shares Gap Up - Here's Why

Pfizer, BioNTech Fail to Void Alnylam's Covid-Shot Patent Claims

BioNTech (BNTX) Projected to Post Earnings on Monday

Decheng Capital LLC Buys Shares of 40,000 BioNTech SE (NASDAQ:BNTX)

BioNTech SE (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Gilder Gagnon Howe & Co. LLC Raises Stock Position in BioNTech SE (NASDAQ:BNTX)

Top Biotech Stocks To Watch Now - April 25th

SMMT Stock Declines Amid Akeso's FDA Approval News

Merck's (MRK) Keytruda Gains as Akeso and Summit Struggle with Survival Data | BNTX Stock News

Summit Therapeutics (SMMT) Gains Attention Amid New Drug Approval in China | BNTX Stock News

BioNTech (BNTX) Showcases Oncology Advances at AACR 2025

Akeso (AKESF) and Summit Therapeutics (SMMT) See Stock Declines After Drug Data Release | BNTX ...

BioNTech SE (NASDAQ:BNTX) Stock Holdings Lessened by Altrinsic Global Advisors LLC

First Trust Advisors LP Trims Stake in BioNTech SE (NASDAQ:BNTX)

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation ...

BioNTech SE (BNTX) Showcases Oncology Pipeline Progress at AACR 2025 | BNTX stock news

8,767 Shares in BioNTech SE (NASDAQ:BNTX) Acquired by Diadema Partners LP

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025 | The Manila Times

BioNTech (BNTX) to Announce Q1 2025 Financial Results

BioNTech (BNTX) Advances Cancer Treatment Trials and IP Defense

Q1 Earnings Forecast for BioNTech Issued By Leerink Partnrs

Marshall Wace LLP Increases Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE to Announce Q1 2025 Financial Results | BNTX stock news

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 | The Manila Times

BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations

Bridgewater Associates LP Increases Holdings in BioNTech SE (NASDAQ:BNTX)

BioNTech SE (NASDAQ:BNTX) Shares Sold by Capital International Inc. CA

Finward Bancorp Makes New Investment in BioNTech SE (NASDAQ:BNTX)

What the Newest mRNA Vaccines Could Do Beyond COVID
BioNTech (NasdaqGS:BNTX) Sees 11% Stock Increase Over Last Week

BioNTech (BNTX) Dominates German Stocks Among Hedge Funds

BioNTech SE (NASDAQ:BNTX) Shares Sold by Quinn Opportunity Partners LLC

Scotia Capital Inc. Acquires 30,143 Shares of BioNTech SE (NASDAQ:BNTX)

Sen. Johnson demands COVID vaccine makers hand over all documents, communications, as evidence against their products reaches a climax - NaturalNews.com
Latest news
Show more
Bond Market News Today: Alphabet (GOOGL) Back to Corporate Bond Market

Morning Note: Dollar Climbs on Trade Winds; BTC Soars; ECB's Dovish Tone

Stock Market Today: Dow Jones Up, Nvidia stock fluctuates, Nasdaq Rises